10:25am ET
Health and Healthcare
6 Serious Biotech and Health Care Movers
In Thursday morning’s trading session, it seemed almost across the board that biotech stocks were the largest gainers.
Companies
/Healthcare
Mannkind Corp
$3.98
▼ $0.08 (−2.02%) today
Markets open · 11:47am ET
MNKD Coverage
Page 16
6:45am ET
Investing
The 5 Most Shorted Nasdaq Stocks in Mid-December
Among the most heavily shorted stocks traded on the Nasdaq between the November 28 and December 15 settlement dates, only Frontier Communications saw some rise in short interest.
10:00am ET
Health and Healthcare
Are Investors Signaling Optimism in Biotechs Through Short Interest?
The short interest data are out for the November 28 settlement date, and 24/7 Wall St. has reviewed the top biotech companies.
6:53am ET
Investing
The 5 Most Shorted Stocks on the Nasdaq
Among the most heavily shorted Nasdaq stocks between the November 14 and November 28 settlement dates, only BlackBerry saw a significant rise in short interest.
12:10pm ET
Health and Healthcare
MannKind Sees More Insider Selling
MannKind saw its shares trading lower on Thursday. The culprit may simply be insiders selling more shares.
Jon C. Ogg 11:07am ET
Health and Healthcare
Mixed Readings For Biotech Short Interest
ThinkstockThe short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or…
8:40am ET
Health and Healthcare
Biotech Short Interest Becomes Stock Specific (Updated)
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.
7:00am ET
Investing
The 5 Most-Heavily Shorted Nasdaq Stocks
Surges in short interest in Intel and Comcast between the October 15 and October 31 settlement dates made sure they remained near the top of the list of most shorted Nasdaq stocks.
2:00pm ET
Health and Healthcare
MannKind Spending Trends See Improvements
MannKind reported its third-quarter financial results on Monday morning.
Jon C. Ogg 10:30am ET
Health and Healthcare
Biotech Short Interest Becomes Stock Specific
Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.
1:30pm ET
Health and Healthcare
Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade
Goldman Sachs has initiated on MannKind with a Neutral rating and a $6 price target, a move that may seem to some as the equivalent to a downgrade.
Jon C. Ogg 8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AIG, Align Tech, Cliffs, Cyber-Ark, MannKind, Micron and More
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Monday, October 20, 2014.
10:10am ET
Health and Healthcare
Short Interest in Biotech Becomes Company Specific
The short interest data are out for the end of September settlement date, and 24/7 Wall St. has reviewed the top biotech companies.
6:47am ET
Investing
Apple Slips From 5 Most Shorted Nasdaq Stocks
While Apple was slipping down the list of the most shorted stocks on the Nasdaq, it passed Microsoft on the way up.
10:50am ET
Health and Healthcare
Short Sellers Make Moves in Key Biotech Stocks
Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the most recent report.